1. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
   Antonella Sistigu et al, 2017, Cytokine & Growth Factor Reviews CrossRef
2. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
   Roberta Bulla et al, 2016, Nat Commun CrossRef
3. The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis
   Silvio Bandini et al, 2016, OncoImmunology CrossRef
4. The Overlapping Roles of Antimicrobial Peptides and Complement in Recruitment and Activation of Tumor-Associated Inflammatory Cells
   Izzat A. M. Al-Rayahi et al, 2015, Front. Immunol. CrossRef
5. Tumour cell conditioned medium reveals greater M2 skewing of macrophages in the absence of properdin.
   Izzat A M Al-Rayahi et al, 2017, Immun Inflamm Dis CrossRef
6. Plasma proteome plus site‐specific N ‐glycoprofiling for hepatobiliary carcinomas
   Ting‐Tsung Chang et al, 2019, J Pathol Clin Res CrossRef
7. Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma
   Jiadai Xu et al, 2020, Front. Immunol. CrossRef
8. Nanoparticle personalized biomolecular corona: implications of pre-existing conditions for immunomodulation and cancer
   Jacob Shaw et al, 2022, Biomater. Sci. CrossRef
9. Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
   Izzat A. M. Al-Rayahi et al, 2021, Medicina CrossRef